Dermatofibrom
Granskad av Dr Toni Hazell, FRCGPSenast uppdaterad av Dr Rosalyn Adleman, MRCGPSenast uppdaterad 14 mars 2025
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Medicinska yrkesverksamma
Professionella referensartiklar är utformade för att användas av hälso- och sjukvårdspersonal. De är skrivna av brittiska läkare och baserade på forskningsbevis, brittiska och europeiska riktlinjer. Du kanske hittar en av våra hälsoartiklar mer användbar.
Synonym: fibrous histiocytoma
What are dermatofibromas?
Dermatofibromas are common and benign skin tumours but frequently cause concern upon discovery.
Causes of dermatofibromas (aetiology)
Traditionally, dermatofibromas were attributed to a reaction to trauma such as insect bites. However, the precise aetiology is unclear. Some believe them to be benign neoplasms rather than reactive in origin.
The most common dermatofibromas contain a mixture of fibroblasts, macrophages and blood vessels. Most involve the dermis and may extend to the subcutis. A number of less common variants where the histology differs, such as the aneurysmal fibrous histiocytoma, hemosiderotic fibrous histiocytoma, cellular fibrous histiocytoma and epithelioid fibrous histiocytoma, have been described.1 Different types are associated with different behaviours and outcomes.
How common are dermatofibromas? (Epidemiology) 23
They are common but determining global incidence is challenging as most patients are asymptomatic and do not seek medical attention.
They are more frequent in women than in men.
They can occur at any age, most commonly in young adulthood.
They occur in all ethnicities.
They are more common and more numerous in those with immunosuppression.
Symptoms of dermatofibromas (presentation)3 4
Dermatofibromas are usually single nodules that develop on an extremity, most commonly the lower legs. They are freely moving, firm-to-hard nodules of 0.5-1.0 cm diameter.
The skin's surface is generally smooth, occasionally scaly. The overlying skin may be tethered, causing it to dimple when pinched. The skin colour varies from skin-coloured to pink/red to cream/white to brown.
Dermatofibromas can occur at någon skin site and individuals may have several lesions (up to 15).
Multiple variants tend to occur where immunity is impaired (eg, autoimmune disease, systemic lupus erythematosus, HIV, leukaemia).
The nodule is usually asymptomatic but can be itchy or tender.
After initial growth, they tend to remain static in size.
Dermatofibroma - close-up view

Diagnosis of dermatofibromas
Diagnosis is usually straightforward provided you palpate the lesion, as few other skin lesions are as firm.
The pinch test is helpful (but not definitive): squeezing the lesion from the sides results in dimpling of overlying skin.
With a dermatoscope, dermatofibromas typically show a pigment network and central white patch but there is considerable variation.5 One study noted a difference in dermatoscopy appearance depending on location of the lesion.6
Excision biopsy is useful where diagnostic uncertainty remains after examination.
Differentialdiagnos
Inkluderar:
Keloid or hypertrophic scar.
Metastatic carcinoma of the skin.
Spitz' naevus.
Deep penetrating dermatofibromas may be difficult to distinguish, even histologically, from rare malignant fibrohistiocytic tumours - eg, dermatofibrosarcoma protuberans.7
Management of dermatofibromas
Reassure - generally no treatment is required.
Remove where cosmetically disliked, symptomatic or there is diagnostic uncertainty. Note that there is a significant local recurrence rate.
Removal by elliptical excision or punch biopsy usually provides the most satisfactory results: shave excision or cryotherapy have higher risks of incomplete excision and recurrence.
A Dutch study showed about 2% of GP subcutis excisions yield unexpected or rare malignancies, and UK studies have shown a lack of reliability in GP diagnosis of skin malignancy.8 9 Therefore, even where excision is for cosmetic or symptomatic reasons, it is nonetheless worth sending specimens to histology.
När remiss bör skickas
Referral is normally indicated only for diagnostic uncertainty, to differentiate from other potentially harmful pigmented lesions.
Prognos
Dermatofibromas are almost invariably benign - there are extremely rare case reports of metastasising cellular dermatofibromas, although histological distinction from other tumours can prove difficult.10 Follow up lesions that are histologically atypical or undergo recurrence.
Most are static and persist indefinitely although, uncommonly, they spontaneously regress.
The cellular type tends to become larger and, as above, has occasionally been reported to metastasise.
They may become repeatedly irritated - by shaving, for example.
Exklusiva uppdateringar för vårdpersonal
Håll dig informerad med de senaste kliniska uppdateringarna, professionella insikter och evidensbaserad vägledning. Patient Pro-nyhetsbrevet sammanställer viktigt innehåll för vårdpersonal—levererat direkt till din inkorg.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.
Vidare läsning och referenser
- Higgins JC, Maher MH, Douglas MS; Diagnostik av vanliga godartade hudtumörer. Am Fam Physician. 1 okt. 2015;92(7):601–7.
- Marghoob AA, Usatine RP, Jaimes N; Dermoscopy for the family physician. Am Fam Physician. 2013 Oct 1;88(7):441-50.
- Myers DJ, Fillman EP; Dermatofibroma. StatPearls, Sept 2021.
- Dermatofibrom; DermIS.
- Alves JV, Matos DM, Barreiros HF, et al; Variants of dermatofibroma--a histopathological study. An Bras Dermatol. 2014 May-Jun;89(3):472-7.
- Myers DJ, Fillman EP. Dermatofibroma. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan
- Dermatofibrom; Primary Care Dermatology Society
- Dermatofibrom; DermNet NZ
- Zaballos P, Puig S, Llambrich A, et al; Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol. 2008 Jan;144(1):75-83.
- Brancaccio G, Nuzzo T, Di Maio R, et al; Dermatofibroma looks dermoscopically different on trunk vs extremities. G Ital Dermatol Venereol. 2015 Dec 23.
- Hanly AJ, Jorda M, Elgart GW, et al; High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors. Arch Pathol Lab Med. 2006 Jun;130(6):831-4.
- Buis PA, Verweij W, van Diest PJ; Value of histopathologic analysis of subcutis excisions by general practitioners. BMC Fam Pract. 2007 Jan 26;8:5.
- George S, Pockney P, Primrose J, et al; A prospective randomised comparison of minor surgery in primary and secondary care. The MiSTIC trial. Health Technol Assess. 2008 May;12(23):iii-iv, ix-38.
- Bandarchi B, Ma L, Marginean C, et al; D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. Mod Pathol. 2010 Mar;23(3):434-8. Epub 2010 Jan 8.
Om recensentenVisa fullständig biografi

Dr Toni Hazell, FRCGP
MBBS, BSc, FRCGP, DFSRH, Dip GU med, DRCOG, DCH (London, UK, 2000)
Dr. Toni Hazell tog examen från St. Mary’s Hospital Medical School och genomförde sin VTS vid Northwick Park Hospital.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Nästa granskning förfaller: 13 mars 2028
14 mars 2025 | Senaste versionen
Mer inom dermatologi
- Gikt
- Herpesvirus
- Hidradenitis suppurativa
- Hyposensibilisering
- Ichthyosis hystrix
- Impetigo
- Spädbarns seborroisk dermatit
- Insektsbett och stick
- Keloidärr
- Linjär IgA-dermatos
- Klumpar
- Mindre kirurgi inom primärvården
- Orbital och preseptal cellulit
- Pemphigoid gestationis
- Köns- och kroppslöss
- PUVA
- Hudmanifestationer av systemisk sjukdom
- Toxokarias
- Xanthelasma


